BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Prognosis
32 results:

  • 1. Mechanisms Involved in Therapeutic Effects of
    Bayat Z; Mazaheri T; Farhadifard H; Taherkhani A
    Biomed Res Int; 2024; 2024():1236910. PubMed ID: 38322303
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. C2orf48 promotes the progression of nasopharyngeal carcinoma by regulating high mobility group AT-hook 2.
    Jiang Y; Liang F; Chen R; Huang Y; Xiao Z; Zeng H; Han P; Huang X
    Med Oncol; 2023 Sep; 40(11):306. PubMed ID: 37755629
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated hmga2 transcription.
    Yang Z; Liu F; Li Z; Liu N; Yao X; Zhou Y; Zhang L; Jiang P; Liu H; Kong L; Lang C; Xu X; Jia J; Nakajima T; Gu W; Zheng L; Zhang Z
    Clin Epigenetics; 2023 May; 15(1):92. PubMed ID: 37237385
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma.
    Hu Y; Chen J; Liu M; Feng Q; Peng H
    Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36281789
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Construction and validation of a novel prognostic model for thyroid cancer based on N7-methylguanosine modification-related lncRNAs.
    Zhou Y; Dai X; Lyu J; Li Y; Bao X; Deng F; Liu K; Cui L; Cheng L
    Medicine (Baltimore); 2022 Oct; 101(42):e31075. PubMed ID: 36281116
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Circular RNA CircSHKBP1 accelerates the proliferation, invasion, angiogenesis, and stem cell-like properties via modulation of microR-766-5p/high mobility group AT-hook 2 axis in laryngeal squamous cell carcinoma.
    Chen F; Zhang H; Wang J
    Bioengineered; 2022 May; 13(5):11551-11563. PubMed ID: 35502885
    [TBL] [Abstract] [Full Text] [Related]  

  • 7.
    Luan Q; Yang R; Lin L; Li X
    Can J Physiol Pharmacol; 2022 Feb; 100(2):158-166. PubMed ID: 35080988
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas.
    De Vita A; Vanni S; Fausti V; Cocchi C; Recine F; Miserocchi G; Liverani C; Spadazzi C; Bassi M; Gessaroli M; Campobassi A; De Luca G; Pieri F; Farnedi A; Franchini E; Ferrari A; Domizio C; Cavagna E; Gurrieri L; Bongiovanni A; Riva N; Calpona S; Di Menna G; Debonis SA; Ibrahim T; Mercatali L
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768995
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. MiR-150 suppressed cell viability, invasion and EMT via hmga2 in oral squamous cell carcinoma.
    Liu DK; Yu S; Li JP; Song WW; Li JH
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):3981-3989. PubMed ID: 34156675
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genes involved in the epithelial-mesenchymal transition in oral cancer: A systematic review.
    Vallina C; López-Pintor RM; González-Serrano J; de Vicente JC; Hernández G; Lorz C
    Oral Oncol; 2021 Jun; 117():105310. PubMed ID: 33901766
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. High-mobility group AT-hook 2 promotes growth and metastasis and is regulated by miR-204-5p in oesophageal squamous cell carcinoma.
    Zhang H; Wu X; Sui Z; Ma Z; Gong L; Meng B; Tang P; Yu Z
    Eur J Clin Invest; 2021 Aug; 51(8):e13563. PubMed ID: 33901298
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Potential Utility of Cell Free High Mobility Group AT-hook 2 (hmga2) as a Prognostic Biomarker in Liquid Biopsies of Oral Squamous Cell Carcinoma.
    Mahmood N; Mushtaq S; Jamal Q; Hanif M; Akhlaq H; Rehman DE; Awan R
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):407-412. PubMed ID: 33639654
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/hmga2 axis in esophageal squamous cell carcinoma.
    Pan Z; Lin J; Wu D; He X; Wang W; Hu X; Zhang L; Wang M
    Aging (Albany NY); 2019 Dec; 11(24):11937-11954. PubMed ID: 31881015
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. hmga2 Contributes to Distant Metastasis and Poor prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma.
    Sakata J; Hirosue A; Yoshida R; Kawahara K; Matsuoka Y; Yamamoto T; Nakamoto M; Hirayama M; Takahashi N; Nakamura T; Arita H; Nakashima H; Nagata M; Hiraki A; Shinohara M; Nakayama H
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109142
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long noncoding RNA HOXC13-AS positively affects cell proliferation and invasion in nasopharyngeal carcinoma via modulating miR-383-3p/hmga2 axis.
    Gao C; Lu W; Lou W; Wang L; Xu Q
    J Cell Physiol; 2019 Aug; 234(8):12809-12820. PubMed ID: 30536950
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The differential regulation of microRNAs is associated with oral cancer.
    Tsai SC; Huang SF; Chiang JH; Chen YF; Huang CC; Tsai MH; Tsai FJ; Kao MC; Yang JS
    Oncol Rep; 2017 Sep; 38(3):1613-1620. PubMed ID: 28713923
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prevalence and significance of hmga2 expression in oesophageal adenocarcinoma.
    Mito JK; Agoston AT; Dal Cin P; Srivastava A
    Histopathology; 2017 Dec; 71(6):909-917. PubMed ID: 28710822
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. High hmga2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
    Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Core‑shell lipid polymer nanoparticles for combined chemo and gene therapy of childhood head and neck cancers.
    Zhang T; Ma J; Li C; Lin K; Lou F; Jiang H; Gao Y; Yang Y; Ming C; Ruan B
    Oncol Rep; 2017 Mar; 37(3):1653-1661. PubMed ID: 28098869
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.